The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 35, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer.
展开▼
机译：本发明提供了分离的肽或衍生自SEQ ID NO：35的片段，其与HLA抗原结合并诱导细胞毒性T淋巴细胞（CTL）。所述肽可包括上述氨基酸序列之一，其中一个，两个或几个氨基酸序列被取代，缺失或添加。本发明还提供了包含这些肽的药物组合物。本发明的肽可用于治疗癌症。
展开▼
